Personalised therapeutic approaches to glioblastoma: A systematic review

INTRODUCTION: Glioblastoma is the most common and malignant primary brain tumour with median survival of 14.6 months. Personalised medicine aims to improve survival by targeting individualised patient characteristics. However, a major limitation has been application of targeted therapies in a non-pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mowforth, Oliver D., Brannigan, Jamie, El Khoury, Marc, Sarathi, Celine Iswarya Partha, Bestwick, Harry, Bhatti, Faheem, Mair, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140534/
https://www.ncbi.nlm.nih.gov/pubmed/37122327
http://dx.doi.org/10.3389/fmed.2023.1166104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140534/
https://www.ncbi.nlm.nih.gov/pubmed/37122327
http://dx.doi.org/10.3389/fmed.2023.1166104

Ejemplares similares